艰难梭菌及其细胞毒素在抗菌药物相关性腹泻及其他病症患者粪便中的情况。
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.
作者信息
George W L, Rolfe R D, Finegold S M
出版信息
J Clin Microbiol. 1982 Jun;15(6):1049-53. doi: 10.1128/jcm.15.6.1049-1053.1982.
Abstract
Fecal specimens from 223 subjects were evaluated for the presence of Clostridium difficile by use of a selective medium developed in our laboratory and for the presence of C. difficile cytotoxin. C. difficile and cytotoxin were detected in 89 and 83%, respectively, of patients with antimicrobial agent-associated pseudomembranous colitis (PMC). In patients in whom PMC was not documented, C. difficile and cytotoxin were present in only 37 and 21%, respectively. C. difficile and cytotoxin were also recovered from the feces of 6 and 3, respectively, of 13 antimicrobial recipients who did not have diarrhea. Although C. difficile appears to be a major cause of PMC, it is not responsible for at least some two-thirds of cases of antimicrobial agent-associated diarrhea in which PMC is not documented. Neither the recovery of C. difficile nor the detection of its cytotoxin should be considered diagnostic for C. difficile-induced disease.
摘要
采用我们实验室研制的一种选择性培养基，对223名受试者的粪便标本进行艰难梭菌检测，并检测艰难梭菌细胞毒素。在患有抗菌药物相关性假膜性结肠炎（PMC）的患者中，分别有89%和83%检测到艰难梭菌和细胞毒素。在未记录有PMC的患者中，艰难梭菌和细胞毒素的检出率分别仅为37%和21%。在13名未出现腹泻的抗菌药物接受者中，分别有6人和3人的粪便中也检出了艰难梭菌和细胞毒素。虽然艰难梭菌似乎是PMC的主要病因，但在至少三分之二未记录有PMC的抗菌药物相关性腹泻病例中，它并不是病因。艰难梭菌的检出及其细胞毒素的检测均不应被视为艰难梭菌所致疾病的诊断依据。
相似文献
1
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.艰难梭菌及其细胞毒素在抗菌药物相关性腹泻及其他病症患者粪便中的情况。
J Clin Microbiol. 1982 Jun;15(6):1049-53. doi: 10.1128/jcm.15.6.1049-1053.1982.
2
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.抗菌药物相关性假膜性结肠炎患者粪便中的艰难梭菌和细胞毒素。
Infection. 1982;10(4):205-8. doi: 10.1007/BF01666910.
3
Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.住院患者腹泻粪便中的艰难梭菌及其细胞毒素。分离株的产毒潜力。
Ann Biol Clin (Paris). 1989;47(2):67-70.
4
Antimicrobial agent-associated colitis and diarrhea: historical background and clinical aspects.抗菌药物相关性结肠炎和腹泻：历史背景与临床方面
Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S208-13. doi: 10.1093/clinids/6.supplement_1.s208.
5
Isolation of Clostridium difficile and detection of cytotoxin in the feces of diarrheic foals in the absence of antimicrobial treatment.在未进行抗菌治疗的情况下，从腹泻马驹粪便中分离艰难梭菌并检测细胞毒素。
J Clin Microbiol. 1987 Jul;25(7):1225-7. doi: 10.1128/jcm.25.7.1225-1227.1987.
6
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.来自不同患者群体的艰难梭菌分离株的分离率和产毒潜力。
Gastroenterology. 1981 Jul;81(1):5-9.
7
Clostridium difficile cytotoxin in a pediatric population.
Am J Dis Child. 1983 Mar;137(3):271-4. doi: 10.1001/archpedi.1983.02140290057015.
8
Relative frequency of Clostridium difficile in patients with diarrheal disease.腹泻病患者中艰难梭菌的相对频率。
J Clin Microbiol. 1981 Jul;14(1):26-31. doi: 10.1128/jcm.14.1.26-31.1981.
9
Clostridium difficile cytotoxin B in adults with diarrhea: a comparison of patients treated or not treated with antibiotics prior to infection.成人腹泻患者中的艰难梭菌细胞毒素B：感染前接受或未接受抗生素治疗患者的比较
Clin Microbiol Infect. 2001 Aug;7(8):447-50. doi: 10.1046/j.1469-0691.2001.00314.x.
10
Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.急性肠道疾病中的抗菌药物与艰难梭菌：1980 - 1982年瑞典的流行病学数据
J Infect Dis. 1985 Mar;151(3):476-81. doi: 10.1093/infdis/151.3.476.
引用本文的文献
1
Pneumonia.肺炎。
Nat Rev Dis Primers. 2021 Apr 8;7(1):25. doi: 10.1038/s41572-021-00259-0.
2
Evaluation of anti-infective-related -associated colitis using the Japanese Adverse Drug Event Report database.使用日本药物不良反应报告数据库评估抗感染相关结肠炎。
Int J Med Sci. 2020 Mar 26;17(7):921-930. doi: 10.7150/ijms.43789. eCollection 2020.
3
Prevalence of isolated from various raw meats in Korea.韩国各种生肉中分离出的[某种物质或微生物]的流行情况。（原文中“isolated from”前缺少具体所指内容）
Food Sci Biotechnol. 2018 Jan 24;27(3):883-889. doi: 10.1007/s10068-018-0318-0. eCollection 2018 Jun.
4
The detrimental impact of extracellular bacterial proteases on wound healing.细胞外细菌蛋白酶对伤口愈合的有害影响。
Int Wound J. 2017 Dec;14(6):1237-1247. doi: 10.1111/iwj.12790. Epub 2017 Jul 25.
5
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.成人艰难梭菌相关性腹泻的抗生素治疗
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004610. doi: 10.1002/14651858.CD004610.pub5.
6
Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.艰难梭菌毒素的快速检测及艰难梭菌感染的实验室诊断
Infection. 2017 Jun;45(3):255-262. doi: 10.1007/s15010-016-0940-9. Epub 2016 Sep 6.
7
Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome.肠道微生物群中网络动力学和代谢相互作用的推断
PLoS Comput Biol. 2015 Jun 23;11(5):e1004338. doi: 10.1371/journal.pcbi.1004338. eCollection 2015 May.
8
Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.非达霉素治疗艰难梭菌感染：最新证据与临床指南
Ther Adv Chronic Dis. 2014 Mar;5(2):69-84. doi: 10.1177/2040622313511285.
9
Emerging therapies for Clostridium difficile infection - focus on fidaxomicin.治疗艰难梭菌感染的新方法 - 重点关注非达霉素。
Infect Drug Resist. 2013 Jun 28;6:41-53. doi: 10.2147/IDR.S24434. Print 2013.
10
Comparison of culture, cytotoxin assay and two EIA tests with clinical diagnosis of Clostridium difficile-associated diarrhea.培养法、细胞毒素检测法以及两种酶免疫测定法与艰难梭菌相关性腹泻临床诊断的比较
Can J Infect Dis. 1994 Jul;5(4):163-7. doi: 10.1155/1994/804205.
本文引用的文献
1
Clinical and laboratory observations in Clostridium difficile colitis.艰难梭菌结肠炎的临床及实验室观察
Am J Clin Nutr. 1980 Nov;33(11 Suppl):2521-6. doi: 10.1093/ajcn/33.11.2521.
2
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae.抗菌药物所致结肠炎和腹泻的治疗与预防。
Gastroenterology. 1980 Aug;79(2):366-72.
3
Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study.结肠镜检查在抗生素相关性结肠炎诊断中的应用。一项前瞻性研究。
Scand J Gastroenterol. 1981;16(4):465-8. doi: 10.3109/00365528109181999.
4
Isolation of Clostridium difficile from the feces and the antibody in sera of young and elderly adults.从年轻人和老年人的粪便中分离出艰难梭菌以及检测其血清中的抗体。
Microbiol Immunol. 1981;25(4):345-51. doi: 10.1111/j.1348-0421.1981.tb00036.x.
5
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.来自不同患者群体的艰难梭菌分离株的分离率和产毒潜力。
Gastroenterology. 1981 Jul;81(1):5-9.
6
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.口服万古霉素治疗抗生素相关性假膜性结肠炎后的症状性复发。
Gastroenterology. 1980 Mar;78(3):431-4.
7
Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters.仓鼠中由产毒素梭状芽孢杆菌引起的克林霉素相关性结肠炎。
J Infect Dis. 1977 Nov;136(5):701-5. doi: 10.1093/infdis/136.5.701.
8
Identification of Clostridium difficile as a cause of pseudomembranous colitis.艰难梭菌被鉴定为伪膜性结肠炎的病因。
Br Med J. 1978 Mar 18;1(6114):695. doi: 10.1136/bmj.1.6114.695.
9
Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters.抗生素相关性结肠炎：抗生素对艰难梭菌及仓鼠疾病的影响。
Rev Infect Dis. 1979 Mar-Apr;1(2):386-97. doi: 10.1093/clinids/1.2.386.
10
Colitis induced by Clostridium difficile.艰难梭菌引起的结肠炎。
Rev Infect Dis. 1979 Mar-Apr;1(2):370-8. doi: 10.1093/clinids/1.2.370.
Zotero 插件